RecalledThisWeek Search
High risk Drugs & MedicationsClass II

Apollo Care Semaglutide Recall

SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care

Updated July 29, 2026

Apollo Care is recalling Semaglutide 7.5mg multi-dose vials because they may contain tiny particles of nylon and silk material. Injecting this product could harm you.

Is the Apollo Care, LLC recalled? Yes. This product was recalled by FDA on July 29, 2026. Details below.

What is recalled

Semaglutide 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, NDC 71170-721-01, manufactured by Apollo Care, LLC, 3801 Mojave Ct, Suite 102, Columbia, MO 65202.

Am I affected

You are affected if you have a Semaglutide vial labeled as Apollo Care with NDC 71170-721-01.

What to do right now

Stop using this medication immediately. Do not inject it. Contact Apollo Care, LLC or your pharmacy to return or dispose of the vial safely. Talk to your doctor about alternative medication options.

The hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Brands affected

Apollo Care, LLC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0755-2026
Classification
Class II
Recalled
July 29, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls